We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.82% | 7.36 | 7.36 | 7.45 | 7.52 | 7.12 | 7.38 | 836,713 | 21:21:00 |
From May 2019 to May 2024
By Nathan Allen
Bayer AG (BAYN.XE) said Tuesday that it has agreed to sell its animal-health unit to Elanco Animal Health Inc. (ELAN) in a cash-and-stock deal valued at $7.6 billion.
Elanco will pay $5.3 billion in cash and Bayer will receive $2.3 billion in Elanco stock. The company said it plans to eventually sell off the Elanco shares over time.
The German chemical-and-pharmaceutical company said the deal, which is subject to antitrust clearance, should close in mid-2020.
In the last fiscal year the unit generated sales of $1.8 billion, Bayer said.
The deal will create the second largest animal health-care company in the world, Bayer said.
Write to Nathan Allen at nathan.allen@dowjones.com
(END) Dow Jones Newswires
August 20, 2019 05:58 ET (09:58 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
